Recipharm anticipates FMD compliance struggles, launches standalone service
Recipharm has revealed that it will be offering a standalone serialization service to companies that have not yet prepared for the upcoming FMD deadline.
Archives for July 5, 2018
GSK taps TrialScope for clinical trial transparency
GlaxoSmithKline has selected TrialScope to facilitate clinical trial disclosure and transparency – as the benefits of patient centricity are paramount, and the risks of poor compliance magnified, says VP.
NEWS IN BRIEF
CRO Pivotal inks investigator-sponsored trial deal for genitourinary cancers
CRO Pivotal is collaborating with the non-profit cancer research association APRO to advance investigator-sponsored trials in bladder and prostate cancers.
UDG buys two US-based firms as it continues to expand commercialization services
UDG Healthcare has acquired two healthcare-focused firms, expanding its global footprint and service offerings – including those in health economics and outcomes research – in a deal worth up to $82.4m.
US FDA clears troubled API plants following two Form 483s, says Dr. Reddy’s
Dr. Reddy’s Laboratories has announced receipt of a US FDA establishment inspection report regarding two active pharmaceutical ingredient plants in Hyderabad, India.
Bain Capital buys DSM Sinochem Pharmaceuticals, ‘fully supports’ API biz
API and finished drug manufacturer DSM Sinochem Pharmaceuticals has been sold to London-based private equity firm, Bain Capital.